Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Agnusdei

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
British Journal of Clinical Pharmacology|March 1, 1978
The effects of intravenous isoxsuprine on blood viscosity in patients with occlusive peripheral arterial diseaseT Di Perri, S Forconi, D Agnusdei, et al.
Journal of Endocrinological Investigation|January 1, 1992
Hyperalgesic activity of parathyroid hormone: clinical findingsC Gennari, D Agnusdei, A Camporeale, et al.
Calcified Tissue International|February 1, 1988
Effects of one-year treatment with estrogens on bone mass, intestinal calcium absorption, and 25-hydroxyvitamin D-1 alpha-hydroxylase reserve in postmenopausal osteoporosisR Civitelli, D Agnusdei, P Nardi, et al.
Calcified Tissue International|August 14, 1998
Age-related decline of bone mass and intestinal calcium absorption in normal malesD Agnusdei, R Civitelli, A Camporeale, et al.
Bone and Mineral|October 1, 1992
Short-term treatment of Paget's disease of bone with ipriflavoneD Agnusdei, A Camporeale, S Gonnelli, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1991
Dose-response bioactivity and bioavailability of salmon calcitonin in premenopausal and postmenopausal womenK Overgaard, D Agnusdei, M A Hansen, et al.
Minerva Endocrinologica|July 1, 1989
[Clinical efficacy of treatment with salmon calcitonin, administered intranasally for 1 year, in stabilized postmenopausal osteoporosis]D Agnusdei, S Gonnelli, A Camporeale, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|November 1, 1992
Dietary L-lysine and calcium metabolism in humansR Civitelli, D T Villareal, D Agnusdei, et al.
Drugs Under Experimental and Clinical Research|January 1, 1989
Metabolic and clinical effects of ipriflavone in established post-menopausal osteoporosisD Agnusdei, F Zacchei, S Bigazzi, et al.
Bone|February 14, 2004
Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture riskJ-Y Reginster, S Sarkar, B Zegels, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
British Journal of Clinical Pharmacology|March 1, 1978
The effects of intravenous isoxsuprine on blood viscosity in patients with occlusive peripheral arterial diseaseT Di Perri, S Forconi, D Agnusdei, et al.
Journal of Endocrinological Investigation|January 1, 1992
Hyperalgesic activity of parathyroid hormone: clinical findingsC Gennari, D Agnusdei, A Camporeale, et al.
Calcified Tissue International|February 1, 1988
Effects of one-year treatment with estrogens on bone mass, intestinal calcium absorption, and 25-hydroxyvitamin D-1 alpha-hydroxylase reserve in postmenopausal osteoporosisR Civitelli, D Agnusdei, P Nardi, et al.
Calcified Tissue International|August 14, 1998
Age-related decline of bone mass and intestinal calcium absorption in normal malesD Agnusdei, R Civitelli, A Camporeale, et al.
Bone and Mineral|October 1, 1992
Short-term treatment of Paget's disease of bone with ipriflavoneD Agnusdei, A Camporeale, S Gonnelli, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1991
Dose-response bioactivity and bioavailability of salmon calcitonin in premenopausal and postmenopausal womenK Overgaard, D Agnusdei, M A Hansen, et al.
Minerva Endocrinologica|July 1, 1989
[Clinical efficacy of treatment with salmon calcitonin, administered intranasally for 1 year, in stabilized postmenopausal osteoporosis]D Agnusdei, S Gonnelli, A Camporeale, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|November 1, 1992
Dietary L-lysine and calcium metabolism in humansR Civitelli, D T Villareal, D Agnusdei, et al.
Drugs Under Experimental and Clinical Research|January 1, 1989
Metabolic and clinical effects of ipriflavone in established post-menopausal osteoporosisD Agnusdei, F Zacchei, S Bigazzi, et al.
Bone|February 14, 2004
Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture riskJ-Y Reginster, S Sarkar, B Zegels, et al.
Pageof 7